Targazyme Inc. Receives Additional U.S Patent Award Designed to Improve Cell Therapy Clinical Efficacy Outcomes – Marketwired (press release)
Genetic Literacy Project |
Targazyme Inc. Receives Additional U.S Patent Award Designed to Improve Cell Therapy Clinical Efficacy Outcomes
Marketwired (press release) This US 9,511,095 patent covers multiple biomolecules on the surface of all therapeutic blood, cord blood and bone marrow cells and their derivative therapeutic cells such as hematopoietic stem cells, mesenchymal stem cells, regulatory T-cells, Natural … Cancer Stem Cells Market Global Industry Volume and Region Analysis 2020 |
